Your browser doesn't support javascript.
loading
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning framework.
Rossi, Sabrina H; Newsham, Izzy; Pita, Sara; Brennan, Kevin; Park, Gahee; Smith, Christopher G; Lach, Radoslaw P; Mitchell, Thomas; Huang, Junfan; Babbage, Anne; Warren, Anne Y; Leppert, John T; Stewart, Grant D; Gevaert, Olivier; Massie, Charles E; Samarajiwa, Shamith A.
Afiliação
  • Rossi SH; Department of Oncology, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Newsham I; Early Cancer Institute, Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Pita S; MRC Cancer Unit, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Brennan K; Department of Oncology, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Park G; Early Cancer Institute, Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Smith CG; Stanford Centre for Biomedical Informatics Research, Department of Medicine and Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
  • Lach RP; Department of Oncology, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Mitchell T; Early Cancer Institute, Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Huang J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Babbage A; Cancer Research UK Major Centre, Cambridge, UK.
  • Warren AY; Department of Oncology, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Leppert JT; Early Cancer Institute, Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Stewart GD; Department of Surgery, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
  • Gevaert O; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Massie CE; MRC Cancer Unit, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
  • Samarajiwa SA; Department of Oncology, University of Cambridge, Hutchison-MRC Research Centre, Cambridge Biomedical Campus, Cambridge, UK.
Sci Adv ; 8(39): eabn9828, 2022 Sep 30.
Article em En | MEDLINE | ID: mdl-36170366

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article